Yao Jiaoli, Kong Qingfeng, Wang Yin, Zhang Yanting, Wang Qinxue
Department of Otolaryngology, Shanxi children's Hospital, Taiyuan, China.
Department of Otolaryngology-Head and Neck Surgery, the Second Hospital, Shanxi Medical University, Taiyuan, China.
Am J Rhinol Allergy. 2023 May;37(3):337-347. doi: 10.1177/19458924221148568. Epub 2023 Feb 17.
Allergic rhinitis (AR) is a chronic nasal inflammation, characterized by nasal epithelial dysfunction. Gene therapy targeting transcription factors is a promising strategy for quenching allergic inflammation, including AR.
This study sought to probe the mechanism of Kruppel-like factor 4 (KLF4) in pyroptosis of nasal mucosal epithelial cells (NEpCs) in AR mice and provide targets for AR treatment.
AR mouse models were established using sensitization with ovalbumin, followed by injection with short hairpin RNA KLF4 (sh-KLF4). AR symptoms were assessed by the times of sneezing and nose rubbing, hematoxylin-eosin, and periodic acid-Schiff staining. Levels of KLF4, nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3), cleaved caspase-1, and N-terminal domain (GSDMD-N) in nasal mucosal tissues were determined by Western blot assay, and levels of interleukin (IL)-1β and IL-18 in nasal lavage fluid were determined by enzyme-linked immunosorbent assay. The binding of KLF4 to the NLRP3 promoter was verified using chromatin immunoprecipitation and dual-luciferase assays. The functional rescue experiment was performed with oe-NLRP3 and sh-KLF4 in AR mice.
KLF4 was upregulated in nasal mucosal tissues of AR mice. KLF4 inhibition reduced the times of sneezing and nose rubbing, inflammatory cell infiltration, and goblet cell hyperplasia in nasal mucosal tissues, and levels of NLRP3, cleaved caspase-1, GSDMD-N, IL-1β, and IL-18. KLF4 was enriched on the NLRP3 promoter and improved NLRP3 expression. NLRP3 overexpression reversed the inhibition of sh-KLF4 on pyroptosis of NEpCs in AR mice.
KLF4 bound to the NLRP3 promoter and promoted pyroptosis of NEpCs in AR mice via activating NLRP3.
变应性鼻炎(AR)是一种慢性鼻炎症,其特征为鼻上皮功能障碍。针对转录因子的基因治疗是一种有前景的抑制包括AR在内的变应性炎症的策略。
本研究旨在探究Kruppel样因子4(KLF4)在AR小鼠鼻黏膜上皮细胞(NEpCs)焦亡中的作用机制,并为AR治疗提供靶点。
采用卵清蛋白致敏建立AR小鼠模型,随后注射短发夹RNA KLF4(sh-KLF4)。通过打喷嚏和擦鼻次数、苏木精-伊红染色及过碘酸-希夫染色评估AR症状。采用蛋白质免疫印迹法检测鼻黏膜组织中KLF4、核苷酸结合寡聚化结构域样受体家族含吡咯结构域蛋白3(NLRP3)、裂解的半胱天冬酶-1及N端结构域(GSDMD-N)的水平,采用酶联免疫吸附测定法检测鼻灌洗液中白细胞介素(IL)-1β和IL-18的水平。采用染色质免疫沉淀和双荧光素酶报告基因检测验证KLF4与NLRP3启动子的结合。在AR小鼠中进行oe-NLRP3和sh-KLF4的功能挽救实验。
KLF4在AR小鼠鼻黏膜组织中表达上调。抑制KLF4可减少AR小鼠打喷嚏和擦鼻次数、鼻黏膜组织中炎性细胞浸润及杯状细胞增生,并降低NLRP3、裂解的半胱天冬酶-1、GSDMD-N、IL-1β和IL-18的水平。KLF4富集于NLRP3启动子上并促进NLRP3表达。NLRP3过表达可逆转sh-KLF4对AR小鼠NEpCs焦亡的抑制作用。
KLF4与NLRP3启动子结合并通过激活NLRP3促进AR小鼠NEpCs焦亡。